Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
40 results
D2.289 - Independent Sensitization to Poultry and Fish in a Young Adult
D2.296 - Heat-Stable Egg Allergens in a Patient With Severe Reactions to Cooked and Raw Hen’s Egg
D2.298 - Diagnostic performance of skin prick testing with fresh and frozen cow's milk in addition to commercial extract in cow’s milk allergy
D2.300 - Food allergy and food sensitization in children with Netherton syndrome
D2.290 - Curcubitaceae allergy, a new enemy identificated in Watermelon
D2.291 - Trends and Patterns Observed Among Suspected Egg-allergic Children in Hong Kong: A 26-year Retrospective Study
D2.292 - Effects of Milk Oral Immunotheraphy on Human Basophils in Children with Cow’s Milk Protein Allergy
D2.293 - Differential Clinical Implications of Peach Allergen Components Pru p 3 and Pru p 7
D2.294 - Clinical Characteristics of Food-Allergic Children with Peripheral Blood Hypereosinophilia
D2.297 - Assessing thresholds for undertaking baked milk food challenges
D2.299 - ARFID: The Hidden Face of Food Allergy?
D2.301 - High Prevalence of Familial Meat Allergy on the Black Sea Coast: Insights into Alpha-Gal Syndrome
D2.449 - Patients with Inadequately Controlled CRSwNP and Blood Eosinophil Count ≥150 cells/µL Experience Benefit with Depemokimab: An Analysis of Data from the Integrated ANCHOR-1/-2 Studies
D2.447 - Phenotyping of Chronic T2 Inflammatory Diseases of the Nose and Paranasal Sinuses and the Algorithm for Biologic Therapy Selection
D2.448 - Recommendations on Patient Education for Biological Therapy in CRSwNP – An EAACI Position Paper
D2.450 - EUFOREA/EPOS Criteria Applied to a Diverse CRSwNP Cohort: Post Hoc Findings from Twice-Yearly depemokimab ANCHOR-1/-2 trials
D2.451 - Real-life upper and lower airway outcomes of long-term dupilumab treatment in patients with severe chronic rhinosinusitis with nasal polyps
D2.452 - Real-World Trends in the Epidemiology and Burden of Chronic Rhinosinusitis with Nasal Polyps Over Time in Germany Reveal Increasing Prevalence and Low Biologic Use
D2.453 - Olfactory outcomes of dupilumab in patients with CRSwNP: A real-world prospective study
D2.455 - Does Biological Therapy Modify NSAID Hypersensitivity? Experience with Omalizumab and Mepolizumab in Patients with Asthma and Nasal Polyps with N-ERD
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download